Odd Swarting and Camilla Appelgren contribute to the Seventh Edition of the Life Sciences Law Review

The seventh edition of the Life Sciences Law Review covers a total of 34 jurisdictions, providing an overview of legal requirements of interest to pharmaceutical, biotechnology and medical device industries.

Odd and Camilla have contributed with the Swedish chapter, which describes the legal landscape in Sweden of requirements throughout the life cycle of a regulated medicinal product or medical device, from discovery to clinical trials, the marketing authorization process, post-approval controls, manufacturing, market access etc.

Below you will find a link to the seventh edition of the Life Sciences Law Review in English.